Operating Segments and Related Information (Tables)

3 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Segment information

Segment information for the three months ended March 31, 2015 and 2014 (in thousands) is as follows:

	Recovery Audit Services – Americas		Recovery Audit Services – Europe/Asia- Pacific			Adjacent Services			Healthcare Claims Recovery Audit Services			Corporate Support			Total
Three Months Ended March 31, 2015
Revenue	$	22,417	$	9,305		$	1,263		$	147		$	—		$	33,132
Net loss															$	(2,958	)
Income tax expense															455
Interest expense (income), net															(42		)
EBIT	$	4,078	$	(442	)	$	(885	)	$	(702	)	$	(4,594	)	(2,545		)
Depreciation of property and equipment	969		153			157			13			—			1,292
Amortization of intangible assets	441		273			32			—			—			746
EBITDA	5,488		(16		)	(696		)	(689		)	(4,594		)	(507		)
Foreign currency transaction (gains) losses on short-term intercompany balances	437		1,318			—			—			(63		)	1,692
Transformation severance and related expenses	56		65			16			—			9			146
Stock-based compensation	—		—			—			—			1,132			1,132
Adjusted EBITDA	$	5,981	$	1,367		$	(680	)	$	(689	)	$	(3,516	)	$	2,463

	Recovery Audit Services – Americas		Recovery Audit Services – Europe/Asia- Pacific			Adjacent Services			Healthcare Claims Recovery Audit Services			Corporate Support			Total
Three Months Ended March 31, 2014
Revenue	$	24,798	$	9,702		$	2,283		$	1,118		$	—		$	37,901
Net loss															$	(3,674	)
Income tax expense															113
Interest expense (income), net															54
EBIT	$	4,084	$	101		$	(1,574	)	$	(2,006	)	$	(4,112	)	(3,507		)
Depreciation of property and equipment	1,256		146			160			120			—			1,682
Amortization of intangible assets	500		307			96			—			—			903
EBITDA	5,840		554			(1,318		)	(1,886		)	(4,112		)	(922		)
Foreign currency transaction (gains) losses on short-term intercompany balances	110		(73		)	—			—			(22		)	15
Acquisition-related charges (benefits)	—		—			19			—			—			19
Transformation severance and related expenses	8		79			143			155			—			385
Stock-based compensation	—		—			—			—			1,021			1,021
Adjusted EBITDA	$	5,958	$	560		$	(1,156	)	$	(1,731	)	$	(3,113	)	$	518